Related Experiment Video
Updated: May 4, 2026
06:35
Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
Published on: April 27, 2016
17.7K
Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment
Sandra J Hamilton1, Gerald F Watts2
1Combined Universities Centre for Rural Health, University of Western Australia, Geraldton, Australia.
The Review of Diabetic Studies : RDS
|January 1, 2014
Summary
Type 2 diabetes (T2D) significantly raises cardiovascular disease risk due to endothelial dysfunction (ED). Current therapies improve ED but high residual risk remains, necessitating new interventions for diabetic patients.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Vascular Biology
Background:
- Type 2 diabetes (T2D) is a major risk factor for cardiovascular disease (CVD).
- Endothelial dysfunction (ED) is an early marker of diabetic vascular disease and predicts CVD risk.
- Pathogenic mechanisms of ED in T2D involve nitric oxide synthase uncoupling, mitochondrial dysfunction, and oxidative stress.
Purpose of the Study:
- To explore the mechanisms of endothelial dysfunction in Type 2 diabetes.
- To evaluate current therapeutic strategies for ED in T2D.
- To highlight the need for novel interventions to reduce residual cardiovascular risk.
Main Methods:
- Review of pathogenic mechanisms of endothelial dysfunction in T2D.
- Analysis of therapeutic interventions targeting hyperglycemia, dyslipidemia, oxidative stress, and inflammation.
- Consideration of studies on endothelial function for testing new therapies.
Main Results:
- Endothelial dysfunction in T2D is multifactorial, involving metabolic and vascular abnormalities.
- Standard treatments (lifestyle, glycemic, lipid agents) partially improve ED but leave significant residual risk.
- Niacin addition to statins is not recommended for patients with low HDL-C and controlled LDL-C.
Conclusions:
- Despite therapeutic advances, residual cardiovascular risk in T2D patients with ED remains a critical issue.
- Further research and well-designed studies are essential to develop effective interventions for ED.
- Targeted therapies addressing the underlying mechanisms of ED are crucial for improving cardiovascular outcomes in T2D.
Related Concept Videos
01:27Diabetic Retinopathy
55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
01:24Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
01:28Diabetic Nephropathy
32
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
01:22Diabetic Neuropathy
59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59
01:26Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
01:20Pathophysiology of Diabetes
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K